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Abstract. Bicellar systems are lipid nanostructures formed by 
long- and short-chained phospholipids dispersed in aqueous 
solution. Because of their attractive combination of lipid 
composition, small size and morphological versatility, bicelles 
became new targets for skin research. Bicelles modify the skin 
biophysical parameters and modulate the skin barrier function 
acting as enhancers for drug penetration. Moreover, these 
aggregates have the ability to penetrate through the narrow 
intercellular spaces of the skin stratum corneum and to reinforce its 
lipid lamellae. Their structures allows for the incorporation of 
different molecules that can be carried through the skin layers. The 
remarkable versatility of bicelles is their most important 
characteristic, which makes it possible their use in different fields. 
These aggregates represent new nanosystems for skin applications. 
In this work we provide an overview of the main properties of 
bicelles and their effects on the skin. 
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Introduction 
 
 Bicelles consist in nanostructures formed by long and short chain 
phospholipid molecules dispersed in aqueous solution [1, 2]. These structures 
represent a fascinating category of versatile and robust lipid assemblies 
whose uses are expanding in several research fields. Bicelles have been 
described as discoidal nanostructures in which a long chain phospholipid, 
usually dimyristoyl-phosphatidylcholine (DMPC), forms a flat bilayer and a 
short chain phospholipid, normally dihexanoyl-phosphatidylcholine (DHPC), 
stabilizes the rim of the structure (Fig. 1). Although this description has been 
observed in several bicellar systems, currently it is known that bicelles may 
display different morphologies depending on the sample preparation and 
experimental conditions.  
 The bicellar structure was developed by Sanders and Schwonek in 
1992 to solve experimental problems of lipid vesicles and micelles as 
membrane models for NMR studies of protein characterization [3]. 
However, the interesting combination of lipid composition, small size and 
morphological versatility made bicelles new targets for skin related 
studies. The lipid bilayered structure of this system, with diameters in the 
range of 15–50 nm and thickness about 4–6 nm, presents optimal 
conditions as potential platforms for applications related to skin research. 
This is because of the structural resemblance of bicelles and lipid layers 
of the skin stratum corneum (SC), the absence of surfactants in the 
composition of  bicelles and the possibility of encapsulating different 




Figure 1. Schematic representation of a bicelle showing the flat bilayer region 
composed of long chain phospholipid, surrounded by a rim of short chain 
phospholipid.  
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 The SC is a bilayered lipid-rich matrix structure with embedded 
keratinocytes that builds the upper strata of skin [4]. One of the SC key 
functions is to control permeability being the main target and the main barrier 
for transdermal drug delivery [5-7]. Perturbations in the structure and lipid 
composition of SC are associated to different diseases [8-10].  In order to 
replace the SC lipids or to provide drugs and other substances needed to 
restore skin functionality, several systems have been designed as skin 
carriers, delivery systems, penetration enhancers, etc. Micelles and liposomes 
are perhaps some of the most used systems for these purposes. However, 
despite their demonstrated beneficial effects, their use has some limitations 
[11, 12]. In fact, the large size of liposomes (usually in the range of 200-500 
nm) makes their penetration in the skin improbable since the approximated 
thickness of the SC intercellular spaces are around 6 - 10 nm [13, 14]. In case 
of micelles, their surfactant components normally produce skin irritation   
[15, 16]. The use of bicelles presents advantages over these two classical 
systems because bicelles exhibit dimensions small enough to pass through the 
narrow SC lipid lamellae, they contain a bilayer for  molecules encapsulation 
and they are formed exclusively by lipids [17, 18].  
 These interesting features of bicelles have been the basis for the new 
research line that is being developed with bicelles. In the last years bicelles 
have been investigated as regard to their structure, function and interaction 
with the skin tissue. The potential of this nanostructures for skin research is 
outstanding since their applications would range from model membranes to 
study the SC lipid behavior to applications such as SC lipids regenerators, 
skin carriers, penetration enhancers or retarders and drug delivery systems 
[19]. These studies gave rise to a consistent basis for considering bicelles as 
new nanosystems for skin applications. 
 In this work, we review the main properties of bicelles and the effects of 
their interaction with the skin in vitro and in vivo. To this aim we focus on two 
systems: the classic one formed by dimyristoylphosphatidylcholine  (DMPC) 
and dihexanoylphosphatidylcholine (DHPC) and another more compatible with 
the skin characteristics formed by dipalmitoylphosphatidylcholine (DPPC) and 
dihexanoylphosphatidylcholine (DHPC).  
 
1. Preparation and morphological characteristics of bicelles  
 
 A typical preparation of bicelles involves hydrating the desired mixture of 
long- and short-chain phospholipids, followed by a series of cycles of freezing, 
thawing, and gentle vortexing until a clear solution is obtained. The archetypal 
model of bicelles is formed by dimyristoyl-phosphatidylcholine (DMPC) as large 
chain phospholipid, and dihexanoyl-phosphatidylcholine (DHPC) as short-chain 
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one. However, in order to imitate better the environment of biological membranes 
or to adapt the systems for an specific effect, bicelles with different lipid 
compositions have been prepared. In this way, DMPC can be doped with 
phospholipids that have identical chain lengths but different headgroups (e.g., 
dimyristoyl-phosphatidylglycerol (DMPG), dimyristoyl-phosphatidylserine 
(DMPS), dimyristoylphosphati-dylethanolamine (DMPE) [20, 21], palmitoyl-
stearoyl-phosphatidylcholine (PSPC) [22] or with cellular lipids such as 
cholesterol and cardiolipin) [23]. Bicelles can also be prepared with dipalmitoyl-
phosphatidylcholine (DPPC) or dilauryl-phosphatidylcholine (DLPC) to vary the 
total bilayer thickness, or with an unsaturated lipid, palmitoyl-oleoyl-
phosphatidylcholine (POPC) to obtain bicelles capable of forming micrometre-
scale lipid domains [24]. Apart from DHPC, the rim of bicelles can be formed by 
a bile-salt derivative such as 3-(cholamidopropyl) dimethylammonio-2-hydroxy-
1-propanesulfonate (CHAPSO) [25]. The so-called ideal bicelle model supposes 
a strict segregation between the two main phospholipids [26]. 
 Depending on the composition, lipid concentration (cL) and the 
long/short chain phospholipid molar ratio (q), bicelles display different 
morphologies. In general, the bigger is the q value, the bigger is the size. 
Inversely, the bigger is cL, the smaller is the size. Temperature also exerts 
important effects on bicelles. In temperatures higher than the melting or 
transition temperature (Tm) of the long chain phospholipid, bicelles undergo 
some morphological transitions and may align in magnetic fields.  
 The spontaneous alignment of bicelles is their most important 
characteristic regarding protein characterization by NMR techniques. It is 
generally accepted that bicelles with q values between 2.8 and 6.5 and lipid 
concentration in the range of 3 – 40% w/w spontaneously align in magnetic 
fields in such a way that the bilayer plane is parallel to the magnetic field, 
giving rise to a 31P NMR spectrum showing two well-resolved resonances. 
The high field resonance corresponds to the long chain phospholipid 
localized in the planar surface of the aggregate, whereas the low field 
resonance is attributed to the short chain phospholipid distributed in the torus 
[3, 27, 28]. The 31P NMR spectra of bicelles are therefore used to diagnose 
the formation of bicelles and to verify the quality of the sample orientation. 
Also these spectra give information on the morphology of the aggregates.  
 Although the classic description of DMPC/DHPC bicelles as disk-shaped 
objects formed by a DMPC bilayer and closed on the edges by DHPC 
molecules is well accepted for bicelles with q < 2.8 at temperatures below the 
Tm of the DMPC, in the last decade, this characterization has been extensively 
debated for bicelles with q > 2.8 and temperatures above DMPC Tm [27-29]. 
 The disk-shaped model is not consistent with the mechanism of bicellar 
alignment as a function of temperature in the magnetic field. According to 
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Ottiger and Bax, disk fusion would be necessary to reach an appropriate size 
for cooperative alignment [30]. The changes in viscosity and sample 
transparency that occur under temperature variations corroborate this 
hypothesis. Rowe and Neal added that the classical model does not explain 
the increase of viscosity at temperatures where alignment begins, which 
suggests the formation of large aggregates [31]. 
 Based on their observations, Nieh et al. proposed a model for bicelles 
with q = 3.2, both with and without lanthanide cations (Ln 3+) [29, 32, 33].  
At temperatures below the Tm of DMPC, the bicelles were disk shaped. As the 
temperature rose and the systems changed from the gel to the liquid crystalline 
phase in the presence of Ln3+, the bicelles fused together in an end-to-end 
manner to form lamellar sheets with perforated holes that were lined with 
DHPC. Further increases in temperature caused phase separation, with the 
formation of DHPC-rich mixed micelles and DMPC-rich oriented lamellae that 
incorporated the DHPC-rich mixed micelles, even at higher temperatures [34]. 
In the absence of Ln3+, bicelles were disk-shaped in the gel phase and chiral 
nematic or “wormlike micelles” in the liquid crystalline phase. These bicelles 
became multilamellar vesicles at higher temperatures.  
 While some authors have proposed that the aligned samples correspond to 
elongated aggregates, which are present when samples become viscous [35], 
others claim that the aligned bicelles are perforated lamellar sheets, which are 
present when the sample viscosity drops and its appearance becomes milky [28, 
30, 36]. This latter model is known as the “Swiss cheese model” (Fig. 2). In a 
comprehensive study, Triba et al. [27] found that both elongated and perforated 
lamellar structures are compatible with the NMR aligned spectra, although they 




Figure 2. Representation of the Swiss cheese model consisting of flat bilayer sheets of 
long chain phospholipid perforated with surrounding short chain phospholipid.  
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 Recently, a comparative study related the morphologies of alignable (q = 
3.5) and non-alignable (q = 2) bicellar systems, cL =20%, with temperature 
changes [37]. 31P-NMR spectra indicated that the q = 2 bicelles exhibited 
isotropic behavior at all temperatures (20-60 ºC), while the q = 3.5 bicelles 
varied considerably with temperature. Even at 20 ºC, a low field resonance 
peak and a broad higher field signal suggested partial orientation of the 
sample with the magnetic field. Just above the DMPC Tm, at 25 ºC, the 
spectrum showed two broad resonances near the positions of those observed 
at 20 ºC. At higher temperatures, the lines became more intense, indicating 
increased magnetic alignment that reached a maximum at 40 ºC. These peaks 
disappeared at higher temperatures and were replaced by a broad signal at 
higher field resonances, which are characteristic of a phase transition from 
bicellar aggregates to larger, slow-moving structures, such as vesicles. There 
was also a gradual up field shift of both peaks with increasing temperature, 
which represents an increase in DMPC bilayer order and the gradual 
incorporation of DHPC molecules into this bilayer. This study suggested that 
increasing temperatures promote the migration of DHPC molecules from the 
edges of the structures to the bilayer area of the alignable bicelles. Depletion 
of DHPC molecules at the edges leads to bilayer fusion, which increases the 
bicellar diameters and improves the alignment up to a certain point at which 
bigger and/or non-flat structures are formed and the alignment is lost.  
 Electron microscopy techniques have proven to be very useful as 
complementary techniques to determine samples’ morphology.  The study of 
these samples by Cryo-SEM and TEM found round aggregates of 
approximately 20 nm for bicelles with q = 2 below Tm and elongated 
aggregates of approximately 2000 nm above Tm. These larger aggregates do 
not align in magnetic fields, although their size and morphology explain the 
increase in viscosity with temperature. At q = 3.5, discoidal bicelles of 
approximately 40 nm were observed below Tm, and extended areas of stacked 
lamellar sheets were observed above Tm. The authors considered these 
aggregates to be the most ordered phase because the best alignments in the 
31P-NMR experiments were obtained at the same temperatures.  
 Van Dam et al. applied Cryo-TEM technique to characterize 
DMPC/DHPC q = 3.2 and cL=5% w/w doped with DMPG and CTAB [28]. 
Through this technique they observed disk shaped structures viewed face-on 
and edge on, threadlike cylindrical micelles and branched toroidal structures 
at 20 ºC, 25 ºC and 30 ºC, respectively. In another study, these authors used 
this technique to investigate the morphology of DMPC/DHPC samples over a 
wide range of cL and q, covering isotropically tumbling bicelles and larger 
aggregates [38]. They concluded that temperature and the ratio q are the 
dominating variables for changing sample morphology, while cL to a lesser 
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extent affects the aggregate structure. They observed at q = 0.5, small, 
possibly disc-shaped aggregates with a diameter of approximately 6 nm. At 
higher q-values, they observed distorted discoidal micelles that tend to sort 
cylindrical micelles similar to those reported by Barbosa-Barros et al. [37].  
 Extensive and comprehensive studies have been reported on bicelle 
morphology and phase behavior [34, 39-42]. Throughout this work, 
researchers have reported that (a) bicelles are disk-shaped nanoaggregates 
at temperatures below the Tm of the long-chain phospholipid; (b) increases 
in temperature cause an initial increase and subsequent drop in viscosity; 
and (c) when the temperature is raised above the long-chain phospholipid 
Tm, bicelles with q > 2.8 undergo morphological transitions from disks to 
elongated micelles, perforated lamellar sheets and mixed multilamellar 
vesicles. 
 However, the studies disagree on the exact morphology of the structures 
when T ≥ Tm and the sample exhibit magnetic alignment. Works describing 
the morphology of bicelles with q < 2.8 at temperatures above the long-chain 
phospholipid Tm are scarce. For these reasons, most recent reports use the 
term “bicelle” to refer only to the sample composition and not the disk-
shaped morphology.  
 
2. Effects of bicelles on the skin 
 
 The motivation for using bicelles in the skin arises from the resemblance 
of these structures to micelles and liposomes. Bicelles combine some of the 
most attractive characteristics of these systems and therefore present several 
advantages for skin applications compared to either micelles or liposomes. 
Bicelle structures contain a bilayer that allows for the incorporation of 
different molecules but are much smaller (approximately 15-40 nm) than a 
regular liposome (≅200 nm). This is due the presence of DHPC molecules on 
the edges of the structures, which control the diameter of the assembly. These 
molecules are responsible for discoidal-shaped bicelles and the formation of 
other structures, such as small vesicles. In fact, systems formed by long alkyl 
chain phospholipids and DHPC have been reported to produce reasonably 
monodisperse unilamellar vesicles that are thermodynamically stable, with 
radii ranging between 10 and 40 nm [43-46]. Several kinetic studies have 
shown that discoidal bicelle morphology is a precursor to small vesicle 
morphology [46, 47]. DHPC molecules solubilize the DMPC bilayer similar 
to a surfactant; however, DHPC is a phospholipid with the same polar head 
group as DMPC. These two lipids differ only in the lengths of their 
hydrophobic chains. The use of systems composed only of lipids avoids 
damage to the skin barrier function caused by surfactants, which is 
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characterized by breaking of the corneocyte envelopes and disorganization of 
the intercellular lipid structures.  
 As already mentioned, above the long chain phospholipid Tm 
(approximately 23 °C for DMPC), DMPC/DHPC bicelles undergo phase 
transitions, changing from small aggregates of approximately 15-20 nm to 
structures bigger than 500 nm. Because skin intercellular spaces lie in the 
range of 6-10 nm and physiological skin temperatures are near 37 ºC, this 
phase transition would present a handicap for skin penetration. DMPC/DHPC 
bicelles are likely not able to penetrate into SC intercellular spaces, and their 
effects are limited to the skin’s surface.  
 A different scenario is obtained if the long chain phospholipid DMPC is 
substituted by another phospholipid with higher Tm, such as DPPC. This 
phospholipid has two additional carbons in its hydrophobic chain and a Tm of 41 
°C. At physiological temperatures, bicelles composed of DPPC and DHPC are 
still small aggregates. Some studies have found that at 37 °C, DMPC/DHPC 
bicelles these structures have dimensions of approximately 15 nm in diameter and 
5.4 nm in thickness. These structures have been shown to penetrate through the 
intercellular spaces of the skin SC and achieve deeper internal layers [48]. 
 
In vitro studies  
 
 Experiments using human and pig SC samples treated with bicelles to 
study the effects of these systems on the SC microstructure have been 
reported. In one of these studies, fresh human SC samples were incubated 
with DMPC/DHPC bicelles with cL = 20% and q = 2 for 18 h at 25 °C. Treated 
and untreated SC samples were cryofixed, cryosubstituted and visualized by 
TEM. No differences, including microstructural alterations and/or apparent 
damage, were observed in images of the treated SC compared with untreated 
samples (Fig. 3A and 3B).  
 Given the small sizes of bicelles (20 nm in diameter and 4.5 nm in 
thickness) and their bilayered structures, the lipid dispersion through the SC 
lamellae and the reinforcement of the SC bilayer area would be expected. 
However, this was not observed, suggesting that these bicelles were not able 
to penetrate or disperse through the SC lipid area [19]. This result was 
clarified by Rodriguez et al. [49] using ATR-FTIR. Th authors reported that 
the application of DMPC/DHPC q = 2 bicelles caused phase transitions in the 
SC lipid conformation from the gel state to the liquid crystalline state. This 
transition would be promoted by the incorporation of phospholipids from 
bicelles in the SC lipid lamellar structure. This process involves an increase 
in the fluidity and/or disorder of the lipids. An analysis of phosphate 
vibrations    only  detected     effects from  DMPC/DHPC  bicelles on lipids at the 
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Figure 3. FSTEM micrograph of (A) native SC and (B) SC treated with 
DMPC/DHPC bicelles. Both images show regular areas of corneocytes, (C), lipid 
intercellular spaces (L) and corneodesmosomes (CD) [19]. 
 
outer layer of the SC, suggesting that the majority of DMPC/DHPC bicelles 
remained in the outermost part of the tissue. This is likely why Barbosa-
Barros et al. [19] did not visualize microstructural differences between 
untreated and treated SC; transitions occurring mainly on the SC surface do 
not imply structural modifications that can be visualized in EM experiments. 
 In another study, DPPC/DHPC bicelles with cL = 10% and q = 3.5 were 
incubated with fresh pig skin SC samples for 18 h at 37 ºC. This 
DPPC/DHPC system was specially developed to obtain improved effects on 
the SC microstructure and better skin penetration at physiological conditions. 
Because the DPPC Tm is 41 ºC, the structures do not undergo phase 
transitions at physiological temperatures (approximately 37 ºC), and small 
bicelle structures are favored during the incubation process. After incubation, 
both treated and untreated SC samples were high pressure frozen (HPF) from 
an initial temperature of 37 ºC, freeze fractured and observed using Cryo-
SEM [48]. These bicelles produced quite different results in the SC than the 
DMPC/DHPC q = 2 system. The DPPC/DHPC system could penetrate and 
interact with the SC, forming lipid vesicles and new lamellar-like structures 
observed by Cryo-SEM (Fig. 4). To study this phenomenon, Rodriguez et al. 
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[50] studied the effects of DPPC/DHPC on SC lipids using ATR-FTIR 
spectroscopy coupled to a tape-stripping methodology. Analysis of the lipid 
organization in terms of chain conformational order and lateral packing 
showed that bicelles hampered the temperature-dependent fluidization of SC 
lipids in the most superficial layers of the SC and led to a lateral packing 
corresponding to a stable hexagonal phase. CH2 stretching and phosphate 
vibrations in the ATR-FTIR spectra of subsequent stripping indicated that 
DPPC/DHPC bicelles penetrated into and were widely distributed in deep 
layers of the SC. These results corroborate the presence of different 
DPPC/DHPC structures inside the SC layers, and bicellar reinforcement of 
the SC structures was observed.  
 Various authors have reported studies of bicellar state-transitions from 
disks to vesicles that were induced by dilution or temperature changes. There 
is a general consensus that these transitions occur in progressive steps, 
implying the coexistence of different aggregates in the medium [28, 39, 51]. 
To study the bicelle-to-vesicle transition, DLS studies were performed by 
Barbosa-Barros et al. 2008 [48]. A DPPC/DHPC sample with q = 3.5 and cL 
= 10% was sequentially diluted with water in seven steps, and each diluted 
sample was measured using DLS at 37 °C to imitate physiological conditions. 
The DLS curves indicated that the hydrodynamic diameter (HD) of the 
structures increased upon dilution from 11.3 nm (assigned to bicelle disks) to 
aggregates larger than 1 μm. The morphologies of the aggregates were 
analyzed using EM, which confirmed the DLS results, indicating a dilution-




Figure 4. Cryo-SEM micrograph of SC treated with DPPC/DHPC bicelles. The white 
arrow shows vesicle structures with sizes around 200 nm and the arrowhead points to 
the lamellar-like structures in the intercellular lipid areas. The black arrow shows a 
corneocytes area [48].  
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 In bicellar systems, the DHPC molecules are found mainly on the edges 
of the disk structures and in the water (as monomers). With increasing 
dilutions, the DHPC concentration in water decreases, and DHPC is 
transferred from the bicelle edges into solution, maintaining monomeric 
equilibrium. Hence, disk diameters increase, and high dilutions lead to the 
fusion and closure of large bilayered disks, forming vesicles. This bicelle-to-
vesicle transition explains the presence of vesicles in the SC intercellular 
spaces treated with DPPC/DHPC [48]. This process would have been 
promoted by the dilution of aggregates because the SC pieces were washed 
with water after incubation. Bicelles that have been transformed into vesicles 
presumably follow a process similar to that observed in the DLS observations 
of diluted bicellar solutions outside of the skin.  
 Regarding the ability of bicelles to encapsulate drugs, Rubio et al. [52] 
performed percutaneous penetration studies with DMPC/DHPC and 
DPPC/DHPC systems with cL = 10% and  q = 2 to evaluate their effects on 
the skin penetration of dichlofenac diethylamide (DDEA). The authors 
reported that the incorporation of DDEA in the bicelles led to markedly 
decreased bicelle sizes, indicating that DDEA tends to be located at the 
bicelle edges, similar to DHPC. Fig. 5 shows Cryo-TEM images of 
DPPC/DHPC bicelles with and without DDEA. Both systems decreased the 
percutaneous absorption of the DDEA compared to an aqueous solution of 
DDEA, suggesting a retarded effect after treatment with bicelles. This effect 
was more marked for the DMPC/DHPC bicelles. This could be related to the 
different Tm values for the two systems. At 37 ºC, DMPC/DHPC (Tm ≈ 23 ºC) 
bicelles were in the liquid crystalline phase, in contrast to the gel phase SC 
lipids (Tm ≈ 60 ºC). However, DPPC/DHPC bicelles (Tm ≈ 41 ºC), were in gel 
phase, similar to the SC lipids. Different mixing behaviour of lipids from 
bicelles with SC lipids could induce different effect on the retention of 
DDEA in the upper layers of the skin. This retarder effect was ascribed in 
part to rigidity in the head groups of bicelle phospholipids caused by the 
carboxyl groups of DDEA. This rigidity would hinder the penetration of 
DDEA through the skin. However, DDEA was likely unable to diffuse out of 
the bicellar systems because of its high affinity for its vehicle.  
 A second percutaneous penetration assay was also performed by these 
authors to evaluate the potential of bicelles as penetration enhancers. In this 
experiment, the skin was pretreated with the bicellar systems (DMPC/DHPC 
and DPPC/DHPC systems with cL = 10% and q = 2) before the application of 
an aqueous DDEA solution. The global results obtained showed that 
pretreatment of the skin with bicelles promotes an increase in the 
percutaneous absorption of DDEA, with no significant differences between 
DMPC/DHPC or DPPC/DHPC systems. These studies suggest that treatment 
Lucyanna Barbosa-Barros et al.  146 
with these bicelle systems prior to drug treatment can enhance drug 
absorption. This enhancement is ascribed to an initial interaction of bicelles 
with the SC that causes some disorganization of the intercellular lipids, which 
are responsible for the SC barrier functionality. These results suggest a route 
to aid the absorption of DDEA through the skin.  
  
In vivo studies  
 
 Non-invasive biophysical studies performed with healthy volunteers have 
evaluated the effects of bicelles on skin in vivo.  These studies report mainly 
on measurements of skin hydration, elasticity, erythema and transepidermal 
water loss (TEWL). Skin hydration and elasticity are useful measures of skin 
water content, distensibility, extensibility and tonicity [53, 54]. Erythema 
indicates skin tolerance [55], while TEWL indicates barrier function integrity 
[56, 57].  
 The application of DMPC/DHPC bicelles with cL = 20% and q = 2 to the 
skin of healthy volunteers has been reported [19]. In this experiment, intra-
individual comparisons of three test areas on the volar forearms of 6 healthy 
Caucasian female (ages 25–38) volunteers with no visible skin abnormalities 
were performed. In the test areas, bicelles, deionized water and control (non-
treated) areas were randomized regarding the test sites on each subject. The 
solutions were applied daily over a period of 10 days, and the skin properties 
were measured each day before application.   
 Successive bicelle applications led to an increase in TEWL from days 0 
to 11. This increase was moderate and did not reach pathological levels, 
which are from 25 to 40 g/m2/h [58, 59]. Decreasing of the skin hydration 
was also observed. Elasticity, in turn, showed improvement with the 
application of bicelles. The changes in the erythema of the skin, considering 
inter- and intra-individual variability, were not indicative of an irritation 
process [60]. The bicelles were found to promote increases in TEWL and 
skin elasticity and harmless decreases in skin hydration.  
 Bicelles act to enhance penetration, causing phase transformations in lipid 
domains that may be relevant to skin permeation [61]. As reported by 
Rodriguez et al. [49], the phase transition of the SC lipid conformation from the 
gel state to the liquid crystalline state, which causes the fluidity of these lipids, 
explains the increase of TEWL in vivo. Compared to other enhancers, bicelles 
would have the additional advantage of not causing skin irritation [62]. 
 Another study reported on the effects of the application of DPPC/DHPC 
bicelles with cL = 20% and q = 2 on the skin of healthy volunteers. The 
results were similar to those obtained with the DMPC/DHPC system, 
although they were more discrete. In a similar way, this system led to an 
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increase in TEWL and a decrease in skin hydration. However, the effects were 
approximately 75% and 50% less intense, respectively, than those obtained 
with the DMPC/DHPC system [63]. This result is not unexpected because the 
DPPC/DHPC system contains less DHPC, so the aggregates formed are 
slightly bigger and have longer bilayer areas, which would exert a protective 
effect on the SC. In addition, as observed in the in vitro studies, this system 
penetrates into the skin SC and reconstitutes its lipids in lipid vesicles inside of 




 The use of bicelles for skin applications is a scientific novelty. This new 
lipid system represents a unique versatile structure that has different effects 
on the skin depending on the self-assembly adopted. Bicelles are effective 
skin carriers due to their size, structure and composition. Although bicelles 
have no aqueous internal compartment for encapsulating drugs, their 
bilayered structure allows for the encapsulation of lipophilic and amphiphilic 
compounds. Additionally, because of their ability to increase the permeability 
of the SC, these structures enhance the penetration of hydrophilic 
components dissolved in aqueous medium. Further, the conversion of bicelles 
into vesicles inside the SC hinders their migration outside of the tissue and 
allows a lipid reinforcement effect on the skin. By modulating their physical 
and chemical characteristics, bicelles may be useful for a wide range of 
applications. Bicelles are therefore promising nanostructures with the 
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